Supplementary legend from A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67

Autor:	Jennifer A. Pietenpol, Carlos L. Arteaga, Sheau-Chiann Chen, Quanhu Sheng, Yu Shyr, Brian D. Lehmann, Ana M. Grau, Ingrid M. Meszoely, Jenny C. Chang, Andres Forero-Torres, Patrick M. Dillon, Jennifer M. Rosenbluth, Violeta Sanchez, Kimberly C. Johnson, Timothy M. Shaver, J. Scott Beeler, Monica V. Estrada, M. Gabriela Kuba, Melinda E. Sanders, Aditya Bardia, Vandana G. Abramson, Erica L. Mayer, Ingrid A. Mayer, Bojana Jovanović
Rok vydání:	2023
Popis:	Supplementary legend
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fcea7f1325a70051293bbe650a03e8 https://doi.org/10.1158/1078-0432.22468100 Zobrazit plný text záznamu